Cloned cattle engineered to carry an artificial chromosome encoding human immunoglobulin genes are a significant leap toward the production of safer and more potent therapeutic antibodies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
© Bob Crimi
References
Kuroiwa, Y. et al. Nat. Biotechnol. 20, 889–894 (2002).
Lonberg, N. & Huszar, D. Intern. Rev. Immunol. 13, 65–93 (1994).
Ishida, I. et al. Cloning Stem Cells 4, 91–102 (2002).
Fishwild, D.M. et al. Nat. Biotechnol. 14, 845–851 (1996).
Mendez, M.J. et al. Nat. Genet. 15, 146–156 (1997).
Tomizuka, K. et al. Nat. Genet. 16, 133–143 (1997).
Stiehm, E.R. Trans. Med. Rev. 10, 203–221 (1996).
Farrugia, A. & Poulis, P. Transfus. Med. 11, 64–74 (2001).
Riedout, W.M., Eggan, K. & Jaenisch, R. Science 293, 1093–1098 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Echelard, Y., Meade, H. Toward a new cash cow. Nat Biotechnol 20, 881–882 (2002). https://doi.org/10.1038/nbt0902-881
Issue Date:
DOI: https://doi.org/10.1038/nbt0902-881
